Skip to main content

FINESSE: testing treatments for prostate cancer

Using an existing medication that slows prostate growth, Finasteride, this trial will test whether the medication can reduce the need for extensive surgery or radiotherapy in men with early stage prostate cancer. The six-year trial will involve 550 men in Yorkshire.

Read the academic trial summary

Finesse - FINassteride evaluation in surveillance for prostate cancer


Professor James Catto

Professor of Urology at the University of Sheffield

Professor Peter Sasieni

Professor of Cancer Prevention at King's College London

Every 17 minutes someone is diagnosed with cancer in Yorkshire

Our aim is for more people to survive cancer, here in Yorkshire and beyond.

Please help us continue to fund life-saving research.

Donate today
Doctor in discussion with a patient during GP appointment